SynthesisFrontiers in endocrinology2026
Comparative efficacy of lipid-lowering therapies on the cardio-renal-metabolic axis in diabetic kidney disease: a Bayesian network meta-analysis addressing residual CRM risk.
Jun Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.